HUE048502T2 - Kondroitin komplexek transzkután abszorpcióra - Google Patents
Kondroitin komplexek transzkután abszorpcióraInfo
- Publication number
- HUE048502T2 HUE048502T2 HUE13747807A HUE13747807A HUE048502T2 HU E048502 T2 HUE048502 T2 HU E048502T2 HU E13747807 A HUE13747807 A HU E13747807A HU E13747807 A HUE13747807 A HU E13747807A HU E048502 T2 HUE048502 T2 HU E048502T2
- Authority
- HU
- Hungary
- Prior art keywords
- transcutaneous absorption
- chondroitin
- complexes
- chondroitin complexes
- transcutaneous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001316A ITMI20121316A1 (it) | 2012-07-27 | 2012-07-27 | Complessi di condroitina ad assorbimento transcutaneo |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE048502T2 true HUE048502T2 (hu) | 2020-07-28 |
Family
ID=46939794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE13747807A HUE048502T2 (hu) | 2012-07-27 | 2013-07-25 | Kondroitin komplexek transzkután abszorpcióra |
Country Status (13)
Country | Link |
---|---|
US (2) | US20150174258A1 (hu) |
EP (1) | EP2877156B1 (hu) |
CN (1) | CN104684542A (hu) |
CA (1) | CA2880012C (hu) |
CY (1) | CY1122538T1 (hu) |
DK (1) | DK2877156T3 (hu) |
ES (1) | ES2765199T3 (hu) |
HK (1) | HK1209334A1 (hu) |
HU (1) | HUE048502T2 (hu) |
IT (1) | ITMI20121316A1 (hu) |
PL (1) | PL2877156T3 (hu) |
RU (1) | RU2642612C2 (hu) |
WO (1) | WO2014016380A1 (hu) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6011734B2 (ja) * | 2014-01-07 | 2016-10-19 | 株式会社村田製作所 | 構造材接合方法および接合構造 |
CN108904449A (zh) * | 2018-08-20 | 2018-11-30 | 广州云雾雾化应用技术研究院(普通合伙) | 一种雾态软骨素在制备修复角膜的药物中的应用 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983000150A1 (en) * | 1981-07-02 | 1983-01-20 | Walton, Alan, G. | Glycosaminoglycan drug complexes |
CA1340994C (en) | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
US5639738A (en) | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
US5792753A (en) | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
AU730495B2 (en) * | 1995-11-13 | 2001-03-08 | North West University | Administration media for analgesic, antiinflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
IT1289613B1 (it) | 1997-02-07 | 1998-10-15 | Inalco Spa | Polisaccaridi batterici o-solfatati |
US6987023B2 (en) | 1998-04-02 | 2006-01-17 | The Board Of Regents Of The University Of Oklahoma | DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
US20030104601A1 (en) | 1999-04-01 | 2003-06-05 | Deangelis Paul L. | Chondroitin synthase gene and methods of making and using same |
CN101275143A (zh) | 1998-04-02 | 2008-10-01 | 俄克拉何马大学董事会 | 编码透明质酸合酶的核酸及其应用方法 |
US6051587A (en) * | 1998-04-16 | 2000-04-18 | Medicure, Inc. | Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
US6482401B1 (en) * | 1998-12-23 | 2002-11-19 | Naturopathic Laboratories International, Inc. | Composition for the relief of joint pain and myofascial pain and method of preparing same |
ITMI991465A1 (it) | 1999-07-02 | 2001-01-02 | Inalco Spa | Processo per la preparazione dei polisaccaridi k4 e k5 da escherichiacoli |
DE60139993D1 (de) | 2000-04-25 | 2009-11-05 | Univ Oklahoma | Chondroitin synthasegen und verfahren zur dessen herstellung und anwendung |
EP1270015A3 (en) * | 2001-06-29 | 2004-02-25 | Sankyo Company Limited | A complex comprising OCIF and Polysaccharide |
JP4702819B2 (ja) | 2001-08-01 | 2011-06-15 | 生化学工業株式会社 | コンドロイチン合成酵素 |
JP4101548B2 (ja) | 2001-08-10 | 2008-06-18 | 生化学工業株式会社 | コンドロイチン合成酵素及びそれをコードするdna |
ITMI20012200A1 (it) | 2001-10-22 | 2003-04-22 | Ibsa Inst Biochimique Sa | Processo per la preparazione di condroitin solfati dal polisaccaride k4 e prodotti ottenuti |
JP4171791B2 (ja) | 2002-04-30 | 2008-10-29 | 独立行政法人産業技術総合研究所 | 糖転移作用剤 |
DE60319529T2 (de) | 2002-05-31 | 2008-10-23 | Seikagaku Corp. | Chondroitinsynthetase und das enzym codierende nukleinsäure |
AU2003241687A1 (en) | 2002-05-31 | 2003-12-19 | Amersham Biosciences K.K. | Chondroitin synthetase and dna coding for the enzyme |
FR2867981B1 (fr) * | 2004-03-24 | 2008-10-31 | Genevrier Sa Lab | Utilisation des chondroitine mono-et disulfates en therapeutique |
US7442682B2 (en) * | 2004-10-19 | 2008-10-28 | Nitto Denko Corporation | Transepithelial delivery of peptides with incretin hormone activities |
JP4932722B2 (ja) | 2005-08-24 | 2012-05-16 | 生化学工業株式会社 | 新規コンドロイチン画分製造方法 |
WO2007058252A1 (ja) | 2005-11-17 | 2007-05-24 | Seikagaku Corporation | コンドロイチンの製造方法 |
EP1964924B1 (en) | 2005-12-15 | 2015-09-30 | Seikagaku Corporation | Long-chain chondroitin sugar chain and method for producing the same and method for promoting synthesis of chondroitin |
CN101466833B (zh) | 2006-06-12 | 2011-10-19 | 生化学工业株式会社 | 经修饰的软骨素合酶多肽及其晶体 |
EP2106798A1 (en) * | 2008-04-02 | 2009-10-07 | Nestec S.A. | Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair |
JP2010173990A (ja) * | 2009-01-30 | 2010-08-12 | Alpha-Nano-Medica Co Ltd | 遺伝子治療剤 |
IT1394311B1 (it) | 2009-05-25 | 2012-06-06 | Altergon Sa | Produzione biotecnologica di condroitina |
ES2661593T3 (es) * | 2010-03-01 | 2018-04-02 | Seikagaku Corporation | Composiciones y métodos para producción bacteriana de condroitina |
US20120094951A1 (en) * | 2010-10-15 | 2012-04-19 | Mark Robinson | Compositions |
-
2012
- 2012-07-27 IT IT001316A patent/ITMI20121316A1/it unknown
-
2013
- 2013-07-25 HU HUE13747807A patent/HUE048502T2/hu unknown
- 2013-07-25 DK DK13747807.9T patent/DK2877156T3/da active
- 2013-07-25 RU RU2015102000A patent/RU2642612C2/ru active
- 2013-07-25 ES ES13747807T patent/ES2765199T3/es active Active
- 2013-07-25 WO PCT/EP2013/065733 patent/WO2014016380A1/en active Application Filing
- 2013-07-25 CN CN201380039164.9A patent/CN104684542A/zh active Pending
- 2013-07-25 EP EP13747807.9A patent/EP2877156B1/en active Active
- 2013-07-25 US US14/416,669 patent/US20150174258A1/en not_active Abandoned
- 2013-07-25 PL PL13747807T patent/PL2877156T3/pl unknown
- 2013-07-25 CA CA2880012A patent/CA2880012C/en active Active
-
2015
- 2015-10-14 HK HK15110058.1A patent/HK1209334A1/xx unknown
-
2018
- 2018-09-07 US US16/124,269 patent/US10675270B2/en active Active
-
2020
- 2020-01-30 CY CY20201100079T patent/CY1122538T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2765199T3 (es) | 2020-06-08 |
RU2642612C2 (ru) | 2018-01-25 |
US20150174258A1 (en) | 2015-06-25 |
ITMI20121316A1 (it) | 2014-01-28 |
US20190000803A1 (en) | 2019-01-03 |
CN104684542A (zh) | 2015-06-03 |
DK2877156T3 (da) | 2020-03-02 |
HK1209334A1 (en) | 2016-04-01 |
RU2015102000A (ru) | 2016-09-20 |
EP2877156A1 (en) | 2015-06-03 |
EP2877156B1 (en) | 2020-01-01 |
WO2014016380A1 (en) | 2014-01-30 |
CA2880012A1 (en) | 2014-01-30 |
CY1122538T1 (el) | 2021-01-27 |
US10675270B2 (en) | 2020-06-09 |
CA2880012C (en) | 2021-05-04 |
PL2877156T3 (pl) | 2020-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2200040I1 (hu) | Benzimidazol-prolin származékok | |
HK1213444A1 (zh) | 癌症的治療 | |
HK1207307A1 (en) | Radio-pharmaceutical complexes | |
HK1211475A1 (en) | Combination therapy | |
HK1203948A1 (en) | Triazolopyrazine derivatives | |
EP2902677A4 (en) | SLIDING PART | |
EP2931290A4 (en) | PORPHYRINE-MODIFIED TELODENDRIMERS | |
HK1205740A1 (en) | Pyrrolotriazinone derivatives | |
ZA201502175B (en) | Oxazolidin-2-one-pyrimidine derivatives | |
GB201217439D0 (en) | Combination therapy | |
GB201207305D0 (en) | Therapy | |
HK1210426A1 (en) | Combination therapy | |
EP2934500A4 (en) | COMBINATION THERAPY AGAINST CANCER | |
HK1209334A1 (en) | Chondroitin complexes for transcutaneous absorption | |
EP2833099A4 (en) | COORDINATE CONVERTERS | |
IL239231A0 (en) | Combined cancer treatment | |
GB201210358D0 (en) | Complexes | |
IL223910A0 (en) | Absorption system | |
ZA201303151B (en) | Portal cover | |
GB201211543D0 (en) | Combination therapy | |
GB201207119D0 (en) | Hamason hinges |